D'Aoust MA - Search Results

1

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.

Hager KJ, Pérez Marc G, Gobeil P, Diaz RS, Heizer G, Llapur C, Makarkov AI, Vasconcellos E, Pillet S, Riera F, Saxena P, Geller Wolff P, Bhutada K, Wallace G, Aazami H, Jones CE, Polack FP, Ferrara L, Atkins J, Boulay I, Dhaliwall J, Charland N, Couture MMJ, Jiang-Wright J, Landry N, Lapointe S, Lorin A, Mahmood A, Moulton LH, Pahmer E, Parent J, Séguin A, Tran L, Breuer T, Ceregido MA, Koutsoukos M, Roman F, Namba J, D'Aoust MA, Trepanier S, Kimura Y, Ward BJ; CoVLP Study Team. Hager KJ, et al. N Engl J Med. 2022 Jun 2;386(22):2084-2096. doi: 10.1056/NEJMoa2201300. Epub 2022 May 4. N Engl J Med. 2022. PMID: 35507508 Free PMC article. Clinical Trial.

2

Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.

D'Aoust MA, Lavoie PO, Couture MM, Trépanier S, Guay JM, Dargis M, Mongrand S, Landry N, Ward BJ, Vézina LP. D'Aoust MA, et al. Plant Biotechnol J. 2008 Dec;6(9):930-40. doi: 10.1111/j.1467-7652.2008.00384.x. Plant Biotechnol J. 2008. PMID: 19076615 Free article.

3

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.

D'Aoust MA, Couture MM, Charland N, Trépanier S, Landry N, Ors F, Vézina LP. D'Aoust MA, et al. Plant Biotechnol J. 2010 Jun;8(5):607-19. doi: 10.1111/j.1467-7652.2009.00496.x. Epub 2010 Feb 18. Plant Biotechnol J. 2010. PMID: 20199612 Free article. Review.

4

Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines.

Ward BJ, Landry N, Trépanier S, Mercier G, Dargis M, Couture M, D'Aoust MA, Vézina LP. Ward BJ, et al. Vaccine. 2014 Oct 21;32(46):6098-106. doi: 10.1016/j.vaccine.2014.08.079. Epub 2014 Sep 19. Vaccine. 2014. PMID: 25240757 Clinical Trial.

5

Generation and characterization of a trackable plant-made influenza H5 virus-like particle (VLP) containing enhanced green fluorescent protein (eGFP).

Young KR, Arthus-Cartier G, Yam KK, Lavoie PO, Landry N, D'Aoust MA, Vézina LP, Couture MM, Ward BJ. Young KR, et al. FASEB J. 2015 Sep;29(9):3817-27. doi: 10.1096/fj.15-270421. Epub 2015 Jun 2. FASEB J. 2015. PMID: 26038124

6

Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19.

Ward BJ, Gobeil P, Séguin A, Atkins J, Boulay I, Charbonneau PY, Couture M, D'Aoust MA, Dhaliwall J, Finkle C, Hager K, Mahmood A, Makarkov A, Cheng MP, Pillet S, Schimke P, St-Martin S, Trépanier S, Landry N. Ward BJ, et al. Nat Med. 2021 Jun;27(6):1071-1078. doi: 10.1038/s41591-021-01370-1. Epub 2021 May 18. Nat Med. 2021. PMID: 34007070 Free PMC article. Clinical Trial.

7

Development and characterization of a plant-derived rotavirus-like particle vaccine.

Kurokawa N, Lavoie PO, D'Aoust MA, Couture MM, Dargis M, Trépanier S, Hoshino S, Koike T, Arai M, Tsutsui N. Kurokawa N, et al. Vaccine. 2021 Aug 16;39(35):4979-4987. doi: 10.1016/j.vaccine.2021.07.039. Epub 2021 Jul 26. Vaccine. 2021. PMID: 34325930

8

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.

Pillet S, Arunachalam PS, Andreani G, Golden N, Fontenot J, Aye PP, Röltgen K, Lehmicke G, Gobeil P, Dubé C, Trépanier S, Charland N, D'Aoust MA, Russell-Lodrigue K, Monjure C, Blair RV, Boyd SD, Bohm RP, Rappaport J, Villinger F, Landry N, Pulendran B, Ward BJ. Pillet S, et al. Cell Mol Immunol. 2022 Feb;19(2):222-233. doi: 10.1038/s41423-021-00809-2. Epub 2022 Jan 5. Cell Mol Immunol. 2022. PMID: 34983950 Free PMC article.

9

Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity.

Hendin HE, Lavoie PO, Gravett JM, Pillet S, Saxena P, Landry N, D'Aoust MA, Ward BJ. Hendin HE, et al. NPJ Vaccines. 2022 Apr 11;7(1):42. doi: 10.1038/s41541-022-00463-3. NPJ Vaccines. 2022. PMID: 35410323 Free PMC article.

10

Regulation of Molecular Farming Products.

Hundleby PAC, D'Aoust MA, Finkle C, Atkins J, Twyman RM. Hundleby PAC, et al. Methods Mol Biol. 2022;2480:313-333. doi: 10.1007/978-1-0716-2241-4_17. Methods Mol Biol. 2022. PMID: 35616870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page